Obesity, adipokines and cancer: An update

Clinical Endocrinology

Volumn 83, Issue 2, 2015, Pages 147-156

  Lee, C H ^a   Woo, Y C ^a   Wang, Y ^b   Yeung, C Y ^a   Xu, A ^a   Lam, K S L ^a,b,c  

^a QUEEN MARY HOSPITAL   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; INTERLEUKIN 6; LEPTIN; TUMOR NECROSIS FACTOR ALPHA; HORMONE; IL6 PROTEIN, HUMAN;

ADIPOSE TISSUE; BREAST CANCER; CARCINOGENESIS; DIFFERENTIATED THYROID CANCER; DIGESTIVE SYSTEM CANCER; DISEASE ASSOCIATION; ENDOMETRIUM CANCER; HEMATOLOGIC MALIGNANCY; HUMAN; HYPOADIPONECTINEMIA; KIDNEY CANCER; MALIGNANT NEOPLASTIC DISEASE; MOLECULAR PATHOLOGY; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; FEMALE; INFLAMMATION; MALE; METABOLISM; NEOPLASMS;

ADIPOKINES; ADIPONECTIN; ADIPOSE TISSUE; ANIMALS; FEMALE; HORMONES; HUMANS; INFLAMMATION; INTERLEUKIN-6; LEPTIN; MALE; NEOPLASMS; OBESITY; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84937141032     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/cen.12667     Document Type: Review

References (72)

1. Renehan, A.G., Tyson, M., Egger, M., et al,. (2008) Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet, 371, 569-578.
2. Calle, E.E., Rodriguez, C., Walker-Thurmond, K., et al,. (2003) Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. The New England Journal of Medicine, 348, 1625-1638.
3. Bhaskaran, K., Douglas, I., Forbes, H., et al,. (2014) Body-mass index and risk of 22 specific cancers: a population-based cohort study of 5.24 million UK adults. Lancet, 384, 755-765.
4. Parr, C.L., Batty, G.D., Lam, T.H., et al,. (2011) Body-mass index and cancer mortality in the Asia-Pacific Cohort Studies Collaboration: pooled analyses of 424,519 participants. The Lancet. Oncology, 11, 741-752.
5. Consultation, W.H.O.E., (2004) Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet, 363, 157-163.
6. Yeung, C.Y., Tso, A.W., Xu, A., et al,. (2013) Pro-inflammatory adipokines as predictors of incident cancers in a Chinese cohort of low obesity prevalence in Hong Kong. PLoS ONE, 8, e78594.
7. Chan, D.S., Vieira, A.R., Aune, D., et al,. (2014) Body mass index and survival in women with breast cancer-systematic literature review and meta-analysis of 82 follow-up studies. Annals of Oncology, 25, 1901-1914.
8. Cao, Y., &, Ma, J., (2011) Body mass index, prostate cancer-specific mortality, and biochemical recurrence: a systematic review and meta-analysis. Cancer Prevention Research (Philadelphia, Pa.), 4, 486-501.
9. Perez-Hernandez, A.I., Catalan, V., Gomez-Ambrosi, J., et al,. (2014) Mechanisms linking excess adiposity and carcinogenesis promotion. Frontiers in Endocrinology, 5, 65.
10. Park, J., Morley, T.S., Kim, M., et al,. (2014) Obesity and cancer-mechanisms underlying tumour progression and recurrence. Nature Reviews. Endocrinology, 10, 455-465.
11. Raucci, R., Rusolo, F., Sharma, A., et al,. (2013) Functional and structural features of adipokine family. Cytokine, 61, 1-14.
12. Harvey, A.E., Lashinger, L.M., &, Hursting, S.D., (2011) The growing challenge of obesity and cancer: an inflammatory issue. Annals of the New York Academy of Sciences, 1229, 45-52.
13. Arner, E., Forrest, A.R., Ehrlund, A., et al,. (2014) Ceruloplasmin is a novel adipokine which is overexpressed in adipose tissue of obese subjects and in obesity-associated cancer cells. PLoS ONE, 9, e80274.
14. Hui, X., Lam, K.S., Vanhoutte, P.M., et al,. (2012) Adiponectin and cardiovascular health: an update. British Journal of Pharmacology, 165, 574-590.
15. Wang, Y., Lam, K.S., Xu, J.Y., et al,. (2005) Adiponectin inhibits cell proliferation by interacting with several growth factors in an oligomerization-dependent manner. Journal of Biological Chemistry, 280, 18341-18347.
16. Dalamaga, M., Diakopoulos, K.N., &, Mantzoros, C.S., (2012) The role of adiponectin in cancer: a review of current evidence. Endocrine Reviews, 33, 547-594.
17. Hebbard, L., &, Ranscht, B., (2014) Multifaceted roles of adiponectin in cancer. Best Practice & Research. Clinical Endocrinology & Metabolism, 28, 59-69.
18. Duan, X.S., Lu, J., Ge, Z.H., et al,. (2013) Effects of T-cadherin expression on B16F10 melanoma cells. Oncology Letters, 5, 1205-1210.
19. Wang, Y., Lam, K.S., &, Xu, A., (2007) Adiponectin as a negative regulator in obesity-related mammary carcinogenesis. Cell Research, 17, 280-282.
20. Macis, D., Gandini, S., Guerrieri-Gonzaga, A., et al,. (2012) Prognostic effect of circulating adiponectin in a randomized 2 x 2 trial of low-dose tamoxifen and fenretinide in premenopausal women at risk for breast cancer. Journal of Clinical Oncology, 30, 151-157.
21. Macis, D., Guerrieri-Gonzaga, A., &, Gandini, S., (2014) Circulating adiponectin and breast cancer risk: a systematic review and meta-analysis. International Journal of Epidemiology, 43, 1226-1236.
22. Ye, J., Jia, J., Dong, S., et al,. (2014) Circulating adiponectin levels and the risk of breast cancer: a meta-analysis. European Journal of Cancer Prevention, 23, 158-165.
23. Liu, L.Y., Wang, M., Ma, Z.B., et al,. (2013) The role of adiponectin in breast cancer: a meta-analysis. PLoS ONE, 8, e73183.
24. Wang, Y., Lam, J.B., Lam, K.S., et al,. (2006) Adiponectin modulates the glycogen synthase kinase-3beta/beta-catenin signaling pathway and attenuates mammary tumorigenesis of MDA-MB-231 cells in nude mice. Cancer Research, 66, 11462-11470.
25. Lam, J.B., Chow, K.H., Xu, A., et al,. (2009) Adiponectin haploinsufficiency promotes mammary tumor development in MMTV-PyVT mice by modulation of phosphatase and tensin homolog activities. PLoS ONE, 4, e4968.
26. Dalamaga, M., (2013) Obesity, insulin resistance, adipocytokines and breast cancer: new biomarkers and attractive therapeutic targets. World Journal of Experimental Medicine, 3, 34-42.
27. Paz-Filho, G., Lim, E.L., Wong, M.L., et al,. (2011) Associations between adipokines and obesity-related cancer. Frontiers in Bioscience (Landmark Edition), 16, 1634-1650.
28. Allott, E.H., Masko, E.M., &, Freedland, S.J., (2013) Obesity and prostate cancer: weighing the evidence. European Urology, 63, 800-809.
29. Stevens, V.L., Jacobs, E.J., Sun, J., et al,. (2014) No association of plasma levels of adiponectin and c-peptide with risk of aggressive prostate cancer in the Cancer Prevention Study II Nutrition Cohort. Cancer Epidemiology, Biomarkers & Prevention, 23, 890-892.
30. Nagaraju, G.P., Aliya, S., &, Alese, O.B., (2015) Role of adiponectin in obesity related gastrointestinal carcinogenesis. Cytokine & Growth Factor Reviews, 26, 83-93.
31. Beales, I.L., Garcia-Morales, C., Ogunwobi, O.O., et al,. (2014) Adiponectin inhibits leptin-induced oncogenic signalling in oesophageal cancer cells by activation of PTP1B. Molecular and Cellular Endocrinology, 382, 150-158.
32. Tsukada, T., Fushida, S., Harada, S., et al,. (2011) Adiponectin receptor-1 expression is associated with good prognosis in gastric cancer. Journal of Experimental & Clinical Cancer Research, 30, 107.
33. Kamada, Y., Matsumoto, H., Tamura, S., et al,. (2007) Hypoadiponectinemia accelerates hepatic tumor formation in a nonalcoholic steatohepatitis mouse model. Journal of Hepatology, 47, 556-564.
34. Saxena, N.K., Fu, P.P., Nagalingam, A., et al,. (2010) Adiponectin modulates C-jun N-terminal kinase and mammalian target of rapamycin and inhibits hepatocellular carcinoma. Gastroenterology, 139, 1762-1773.
35. Fujisawa, T., Endo, H., Tomimoto, A., et al,. (2008) Adiponectin suppresses colorectal carcinogenesis under the high-fat diet condition. Gut, 57, 1531-1538.
36. Endo, H., Hosono, K., Fujisawa, T., et al,. (2009) Involvement of JNK pathway in the promotion of the early stage of colorectal carcinogenesis under high-fat dietary conditions. Gut, 58, 1637-1643.
37. Joshi, R.K., &, Lee, S.A., (2014) Obesity related adipokines and colorectal cancer: a review and meta-analysis. Asian Pacific Journal of Cancer Prevention, 15, 397-405.
38. Luhn, P., Dallal, C.M., Weiss, J.M., et al,. (2013) Circulating adipokine levels and endometrial cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial. Cancer Epidemiology, Biomarkers & Prevention, 22, 1304-1312.
39. Moon, H.S., Chamberland, J.P., Aronis, K., et al,. (2011) Direct role of adiponectin and adiponectin receptors in endometrial cancer: in vitro and ex vivo studies in humans. Molecular Cancer Therapeutics, 10, 2234-2243.
40. Liao, L.M., Schwartz, K., Pollak, M., et al,. (2013) Serum leptin and adiponectin levels and risk of renal cell carcinoma. Obesity, 21, 1478-1485.
41. Horiguchi, A., Ito, K., Sumitomo, M., et al,. (2008) Decreased serum adiponectin levels in patients with metastatic renal cell carcinoma. Japanese Journal of Clinical Oncology, 38, 106-111.
42. Marcello, M.A., Cunha, L.L., Batista, F.A., et al,. (2014) Obesity and thyroid cancer. Endocrine-Related Cancer, 21, T255-271.
43. Cheng, S.P., Liu, C.L., Hsu, Y.C., et al,. (2013) Expression and biologic significance of adiponectin receptors in papillary thyroid carcinoma. Cell Biochemistry and Biophysics, 65, 203-210.
44. Hofmann, J.N., Liao, L.M., Pollak, M.N., et al,. (2012) A prospective study of circulating adipokine levels and risk of multiple myeloma. Blood, 120, 4418-4420.
45. Sanz-Garcia, C., Nagy, L.E., Lasuncion, M.A., et al,. (2014) Cot/tpl2 participates in the activation of macrophages by adiponectin. Journal of Leukocyte Biology, 95, 917-930.
46. Conde, J., Scotece, M., Abella, V., et al,. (2014) An update on leptin as immunomodulator. Expert Review of Clinical Immunology, 10, 1165-1170.
47. Park, H.Y., Kwon, H.M., Lim, H.J., et al,. (2001) Potential role of leptin in angiogenesis: leptin induces endothelial cell proliferation and expression of matrix metalloproteinases in vivo and in vitro. Experimental & Molecular Medicine, 33, 95-102.
48. Harris, H.R., Tworoger, S.S., Hankinson, S.E., et al,. (2011) Plasma leptin levels and risk of breast cancer in premenopausal women. Cancer Prevention Research (Philadelphia, Pa.), 4, 1449-1456.
49. Niu, J., Jiang, L., Guo, W., et al,. (2013) The association between Leptin Level and Breast Cancer: a Meta-Analysis. PLoS ONE, 8, e67349.
50. Ando, S., &, Catalano, S., (2012) The multifactorial role of leptin in driving the breast cancer microenvironment. Nat Rev Endocrinol, 8, 263-275.
51. Ishikawa, M., Kitayama, J., &, Nagawa, H., (2004) Enhanced expression of leptin and leptin receptor (OB-R) in human breast cancer. Clinical Cancer Research, 10, 4325-4331.
52. Dubois, V., Jarde, T., Delort, L., et al,. (2014) Leptin induces a proliferative response in breast cancer cells but not in normal breast cells. Nutrition and Cancer, 66, 645-655.
53. Colbert, L.S., Wilson, K., Kim, S., et al,. (2014) NILCO biomarkers in breast cancer from Chinese patients. BMC Cancer, 14, 249.
54. Endo, H., Hosono, K., Uchiyama, T., et al,. (2011) Leptin acts as a growth factor for colorectal tumours at stages subsequent to tumour initiation in murine colon carcinogenesis. Gut, 60, 1363-1371.
55. Lee, K.N., Choi, H.S., Yang, S.Y., et al,. (2014) The role of leptin in gastric cancer: clinicopathologic features and molecular mechanisms. Biochemical and Biophysical Research Communications, 446, 822-829.
56. Gasiorowska, A., Talar-Wojnarowska, R., Kaczka, A., et al,. (2013) Role of adipocytokines and its correlation with endocrine pancreatic function in patients with pancreatic cancer. Pancreatology, 13, 409-414.
57. Cheng, S.P., Yin, P.H., Chang, Y.C., et al,. (2010) Differential roles of leptin in regulating cell migration in thyroid cancer cells. Oncology Reports, 23, 1721-1727.
58. Conroy, S.M., Maskarinec, G., Morimoto, Y., et al,. (2013) Non-hodgkin lymphoma and circulating markers of inflammation and adiposity in a nested case-control study: the multiethnic cohort. Cancer Epidemiology, Biomarkers & Prevention, 22, 337-347.
59. Mizutani, H., Fukushima, S., Masuguchi, S., et al,. (2013) Serum levels of leptin receptor in patients with malignant melanoma as a new tumor marker. Experimental Dermatology, 22, 748-749.
60. Chi, M., Chen, J., Ye, Y., et al,. (2014) Adipocytes contribute to resistance of human melanoma cells to chemotherapy and targeted therapy. Current Medicinal Chemistry, 21, 1255-1267.
61. Taniguchi, K., &, Karin, M., (2014) IL-6 and related cytokines as the critical lynchpins between inflammation and cancer. Seminars in Immunology, 26, 54-74.
62. Chatterjee, M., Stuhmer, T., Herrmann, P., et al,. (2004) Combined disruption of both the MEK/ERK and the IL-6R/STAT3 pathways is required to induce apoptosis of multiple myeloma cells in the presence of bone marrow stromal cells. Blood, 104, 3712-3721.
63. Guadagni, F., Ferroni, P., Palmirotta, R., et al,. (2007) TNF/VEGF cross-talk in chronic inflammation-related cancer initiation and progression: an early target in anticancer therapeutic strategy. In vivo, 21, 147-161.
64. Lippi, G., Meschi, T., Nouvenne, A., et al,. (2014) Neutrophil gelatinase-associated lipocalin in cancer. Advances in Clinical Chemistry, 64, 179-219.
65. Tee, M.C., Cao, Y., Warnock, G.L., et al,. (2013) Effect of bariatric surgery on oncologic outcomes: a systematic review and meta-analysis. Surgical Endoscopy, 27, 4449-4456.
66. Ashrafian, H., Ahmed, K., Rowland, S.P., et al,. (2011) Metabolic surgery and cancer: protective effects of bariatric procedures. Cancer, 117, 1788-1799.
67. Khan, S., Shukla, S., Sinha, S., et al,. (2013) Role of adipokines and cytokines in obesity-associated breast cancer: therapeutic targets. Cytokine & Growth Factor Reviews, 24, 503-513.
68. Dalamaga, M., (2013) Interplay of adipokines and myokines in cancer pathophysiology: emerging therapeutic implications. World Journal of Experimental Medicine, 3, 26-33.
69. Coletti, D., Moresi, V., Adamo, S., et al,. (2005) Tumor necrosis factor-alpha gene transfer induces cachexia and inhibits muscle regeneration. Genesis, 43, 120-128.
70. Kim, H.J., Kim, H.J., Yun, J., et al,. (2012) Pathophysiological role of hormones and cytokines in cancer cachexia. Journal of Korean Medical Science, 27, 128-134.
71. Ando, K., Takahashi, F., Kato, M., et al,. (2014) Tocilizumab, a proposed therapy for the cachexia of Interleukin6-expressing lung cancer. PLoS ONE, 9, e102436.
72. He, J., Xi, B., Ruiter, R., et al,. (2013) Association of LEP G2548A and LEPR Q223R polymorphisms with cancer susceptibility: evidence from a meta-analysis. PLoS ONE, 8, e75135.